Incomplete cerebral infarctions are not silent

J Pediatr Hematol Oncol. 2001 Feb;23(2):79-83. doi: 10.1097/00043426-200102000-00002.
No abstract available

MeSH terms

  • Adolescent
  • Anemia, Sickle Cell / complications*
  • Anemia, Sickle Cell / drug therapy
  • Anemia, Sickle Cell / therapy
  • Blood Flow Velocity
  • Bone Marrow Transplantation
  • Brain Damage, Chronic / diagnosis
  • Brain Damage, Chronic / epidemiology
  • Brain Damage, Chronic / etiology*
  • Brain Damage, Chronic / pathology
  • Brain Damage, Chronic / prevention & control
  • Cerebral Infarction / complications*
  • Cerebral Infarction / diagnosis
  • Cerebral Infarction / pathology
  • Cerebral Infarction / prevention & control
  • Cerebrovascular Circulation
  • Child
  • Child, Preschool
  • Cognition Disorders / diagnosis
  • Cognition Disorders / epidemiology
  • Cognition Disorders / etiology*
  • Cognition Disorders / pathology
  • Cognition Disorders / prevention & control
  • Deferoxamine / therapeutic use
  • Diagnostic Imaging / methods*
  • GABA Agonists / therapeutic use
  • Humans
  • Infant
  • Iron Overload / drug therapy
  • Iron Overload / etiology
  • Magnetic Resonance Imaging
  • Neuroprotective Agents / therapeutic use
  • Neuropsychological Tests
  • Platelet Aggregation Inhibitors / therapeutic use
  • Risk Factors
  • Sensitivity and Specificity
  • Transfusion Reaction
  • Ultrasonography, Doppler, Transcranial

Substances

  • GABA Agonists
  • Neuroprotective Agents
  • Platelet Aggregation Inhibitors
  • Deferoxamine